Objective To analyze the testing rate of syphilis in maternal women and the intervention of syphilis infected pregnant women and their babies,to evaluate the effectiveness of Prevention of mother-to-child transmission(PMTCT) project in Xuancheng City. Methods The syphilis data of Xuancheng City during 2013 to 2019 from the PMTCT project information system were used to analyze the indicators of syphilis testing, treatment and follow-up of pregnant women and their newborns. Results The syphilis testing rate of maternal women was 99.97% and increased from 2013 to 2019 in Xuancheng City (χ2trend=33.455,P<0.001).The prevalence of syphilis among maternal women was 5.21‰, and increased from 2013 to 2019 (χ2trend=6.227,P=0.013).Among the 820 positive pregnant women, the treatment rate was 84.51%,the standard treatment rate was 60.98%.The rate of congenital syphilis was 1.98/100,000. Conclusion The syphilis detection rate and treatment rate of infected pregnant women in Xuancheng City all meet the requirements of the project plan.The syphilis PMTCT project was effective in Xuancheng City.
Key words
Syphilis /
Maternal /
Mother to child transmission
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 严兰平.探讨预防梅毒母婴传播的有效措施[J].世界最新医学信息文摘,2016,16(74):185-186.
[2] 崔丹.新疆2012~2014年孕产妇梅毒感染状况及治疗情况分析[D].乌鲁木齐:新疆医科大学,2015.
[3] 国家卫健委.预防艾滋病、梅毒和乙肝母婴传播工作实施方案(2015)http://www.nhc.gov.cn/fys/gzbs/201506/4f2123fa955a44afa75a75da2ad35d6e.shtml.
[4] 芮婷婷,吴炜林,朱敏.2013~2017年芜湖市预防梅毒母婴传播综合干预效果评估[J].现代预防医学,2019,46(22):4084-4088.
[5] 吴颖岚,汤艳,高洁.湖南省孕产妇梅毒检测及干预情况分析[J].中国妇幼保健,2015,30(16):2489-2491.
[6] 牟鸿江,王伟人,杨梅.2012-2014年贵州省预防艾滋病梅毒传播效果分析[J].中国艾滋病性病,2017,23(3):261-263.
[7] 张美萍.濮阳地区无偿献血人群梅毒抗体检测结果及流行情况分析[J].实验与检验医学,2018,36(03):459-461.
[8] 张万宏,方玉蓉,郑熠,等.2010~2015年武汉市梅毒疫情估计分析[J].现代预防医学,2017,44(20):3786-3789.
[9] 张万宏,徐业华,石卫东,等.2010~2015年武汉市梅毒网络报告发病率与人群估计感染率对比分析[J].实用预防医学,2018,25(10):1184-1186.
[10] 张庆武.潍坊地区献血者梅毒感染现状的调查与分析[C].中国输血协会.中国输血协会第八届输血大会论文专辑.中国输血协会:《中国输血杂志》编辑部,2016:120.
[11] 李其田,张庆利.潍坊地区献血者梅毒感染现状的调查与分析[J].中国卫生检验杂志,2016,26(8):1201-1202.